Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-10

FDA Approved: CLINDAMYCIN PHOSPHATE AND TRETINOIN — Original Application (Solaris Pharma Corporation)

View source ↗

Summary

The FDA approved Solaris Pharma Corporation's clindamycin phosphate and tretinoin as an original application, a topical combination product for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Tretinoin (Clindamycin phosphate and tretinoin)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE AND TRETINOIN (CLINDAMYCIN PHOSPHATE AND TRETINOIN)